Center for Scientific Review; Amended Notice of Meeting, 30087 [2015-12545]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 100 / Tuesday, May 26, 2015 / Notices
in addiction research, and focus on
novel, underserved, neglected, complex,
or intractable aspects of the addiction
phenomenon. How novel is the
concept? Does it address important
basic or clinical features/effects that are
not currently or adequately addressed
and/or with a fresh perspective?
2. Feasibility (5 points): Ideas,
concepts and the approaches, measures
and systems derived from them must be
rooted on a rational, scientific or
otherwise cogent background that
would guarantee a modicum of
feasibility given the current challenges
and state of the art in the field of
addiction. How well does the research
agenda describe the gaps in the relevant
areas of science that need to be
addressed by this new approach/
concept to be achieved and
implemented? Does the agenda describe
a logical, feasible plan and timeframe
for addressing those gaps?
3. Importance of the question being
addressed/likelihood of impact (5
points): How effective would the
successful completion of the project be
in addressing addiction, enhancing
prevention, or improving clinical
outcomes? How well does it consider
factors relevant to the ultimate success
of the concept? How well does it
harness innovations from other fields to
the existing addiction knowledge base
toward advancing drug abuse and
addiction research?
Scores from each criterion will be
weighted equally. The score for each
submission will be the sum of the scores
from each of the 5 voting judges, for a
maximum of 75 points. NIDA reserves
the right to make an award to
submissions scoring less than 75 points
if NIDA deems any sufficiently
meritorious. All submissions will be
held until after the deadline is reached
for a simultaneous judging process.
NIDA reserves the right to disqualify
and remove any submission that is
deemed, in NIDA’s or the judging
panel’s discretion, inappropriate,
offensive, defamatory, or demeaning.
NIDA reserves the right not to award
any prizes in case none is found to be
sufficiently meritorious.
The evaluation process will begin by
anonymizing and removing those that
are not responsive to this Challenge or
not in compliance with all of the rules
of eligibility. Submissions that are
responsive and in compliance will
undergo a preliminary review by the
Challenge Judges with expertise in the
relevant areas of science Challenge
Judges will examine all responsive and
compliant submissions, as well
comments from program staff, if any,
and score the submissions in
VerDate Sep<11>2014
17:50 May 22, 2015
Jkt 235001
accordance with the judging criteria
outlined above. Judges will meet to
discuss the most meritorious
submissions. Final recommendations
will be determined by electronic
(majority) vote of the judges.
Challenge Judges
Dr. Nora Volkow, Director, National
Institute on Drug Abuse (NIDA)—Ex
Officio
Dr. Roger Little, Deputy Director,
Division of Basic Neuroscience and
Behavioral Research, NIDA
Dr. David Epstein, Associate Scientist,
Intramural Research Program, NIDA
Dr. David Liu, Team Leader, Medical
Officer, Center for Clinical Trials
Network, NIDA
Dr. Maureen Boyle, Chief, Science
Policy Branch, Office of Science
Policy and Communication, NIDA
Dr. Meyer D. Glantz, Associate Director
for Science, Division of Epidemiology,
Services, and Prevention Research
Dr. Ruben Baler, Health Scientist
Administrator, Science Policy Branch,
Office of Science Policy and
Communication, NIDA
Dr. Steve Grant, Chief, Clinical
Neuroscience Branch, Division of
Clinical Neuroscience and Behavioral
Research, NIDA
Dr. Philip Krieter, Pharmacologist,
Division of Pharmacotherapies and
Medical Consequences of Drug Abuse,
NIDA
Dr. Gerald McLaughlin, Chief, Scientific
Review Branch, Division of
Extramural Research, NIDA
Dated: May 11, 2015.
Nora D. Volkow,
Director, National Institute on Drug Abuse,
National Institutes of Health.
[FR Doc. 2015–12632 Filed 5–22–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
PO 00000
Frm 00051
Fmt 4703
Sfmt 9990
30087
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Mentored Transition to Independence
Review Committee.
Date: June 11–12, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Giuseppe Pintucci, Ph.D.
Scientific Review Officer, Office of Scientific
Review/DERA National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7192, , Bethesda, MD 20892, 301–435–0287,
Pintuccig@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: May 19, 2015.
Carolyn Baum,
Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–12538 Filed 5–22–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Systemic Injury by
Environmental Exposure, June 17, 2015,
08:00 a.m. to June 18, 2015, 05:00 p.m.,
Hyatt Regency Bethesda, One Bethesda
Metro Center, 7400 Wisconsin Avenue,
Bethesda, MD, 20814 which was
published in the Federal Register on
May 13, 2015, 80 FR Pg. 28630.
The meeting will be held on 06/18/
2015–06/19/2015 instead of 06/17/
2015–06/18/2015. The meeting time and
location remains the same. The meeting
is closed to the public.
Dated: May 19, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–12545 Filed 5–22–15; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\26MYN1.SGM
26MYN1
]]>Agencies
[Federal Register Volume 80, Number 100 (Tuesday, May 26, 2015)]
[Notices]
[Page 30087]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-12545]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Systemic
Injury by Environmental Exposure, June 17, 2015, 08:00 a.m. to June 18,
2015, 05:00 p.m., Hyatt Regency Bethesda, One Bethesda Metro Center,
7400 Wisconsin Avenue, Bethesda, MD, 20814 which was published in the
Federal Register on May 13, 2015, 80 FR Pg. 28630.
The meeting will be held on 06/18/2015-06/19/2015 instead of 06/17/
2015-06/18/2015. The meeting time and location remains the same. The
meeting is closed to the public.
Dated: May 19, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-12545 Filed 5-22-15; 8:45 am]
BILLING CODE 4140-01-P
